https://www.selleckchem.com/products/th-257.html
included make it a novel and useful contribution to modelling the colonic microbiota. The purpose of this review was to summarize the triumphs and pitfalls of tyrosine kinase inhibitor (TKI) and immune checkpoint inhibitor (ICI) combinations. A literature review of PubMed was conducted and studies were included if they were classified as a clinical trial and assessed TKI and ICI combinations for solid tumor malignancies. Dates of literature search included January 1, 1988 through September 22, 2019. In the past decade, TKI and ICI monoth
Like
Comment
Share
